IMPALA-2: choice of DLCO as a primary endpoint in aPAP

B. Trapnell (Cincinnati, United States), D. Desai (Austin, United States), B. Chowdhury (Austin, United States)

Source: International Congress 2022 – Chronic cough, airway diseases and methods

Session: Chronic cough, airway diseases and methods
Session type: Thematic Poster
Number: 181

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Trapnell (Cincinnati, United States), D. Desai (Austin, United States), B. Chowdhury (Austin, United States). IMPALA-2: choice of DLCO as a primary endpoint in aPAP. 181

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.